PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+0.32%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.83B
AUM Growth
-$176M
(-8.7%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
48.51%
Holding
93
New
6
Increased
23
Reduced
12
Closed
14
Top Buys
| 1 |
UnitedHealth
UNH
|
$25.5M |
| 2 |
Amgen
AMGN
|
$25.3M |
| 3 |
Stryker
SYK
|
$20.1M |
| 4 |
Johnson & Johnson
JNJ
|
$18.8M |
| 5 |
Insmed
INSM
|
$16.2M |
Top Sells
| 1 |
Legend Biotech
LEGN
|
$41.2M |
| 2 |
Zimmer Biomet
ZBH
|
$39.6M |
| 3 |
Avantor
AVTR
|
$34.3M |
| 4 |
Veeva Systems
VEEV
|
$27.5M |
| 5 |
iShares Russell 2000 ETF
IWM
|
$20.8M |
Sector Composition
| 1 | Healthcare | 97.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Metagenomi
MGX
$67.2M
| $5.17M | 0.26% |
1,267,002
| – | – |
|
52
Cullinan Oncology
CGEM
$456M
| $5.16M | 0.26% |
296,036
+40,069
| +16% | +$699K |
|
53
Alkermes
ALKS
$4.95B
| $4.94M | 0.24% |
205,073
-224,500
| -52% | -$5.41M |
|
54
Apellis Pharmaceuticals
APLS
$3.51B
| $3.18M | 0.16% |
82,952
| – | – |
|
55
Viking Therapeutics
VKTX
$3.02B
| $3.12M | 0.15% |
58,811
+25,984
| +79% | +$1.38M |
|
56
Outset Medical
OM
$245M
| $2.87M | 0.14% |
49,640
-28,229
| -36% | -$1.63M |
|
57
IO Biotech
IOBT
$115M
| $2.74M | 0.14% |
2,341,107
| – | – |
|
58
EyePoint Pharmaceuticals
EYPT
$827M
| $2.55M | 0.13% |
292,926
+122,055
| +71% | +$1.06M |
|
|
TSBX
59
DELISTED
Turnstone Biologics
TSBX
| $2.44M | 0.12% |
932,348
+11,372
| +1% | +$29.8K |
|
60
Generation Bio
GBIO
$40.3M
| $2.22M | 0.11% |
78,791
-83,458
| -51% | -$2.35M |
|
61
Sagimet Biosciences
SGMT
$239M
| $2.22M | 0.11% |
649,006
-153,706
| -19% | -$526K |
|
62
PMV Pharmaceuticals
PMVP
$82.1M
| $2.07M | 0.1% |
1,275,462
| – | – |
|
63
Celldex Therapeutics
CLDX
$1.57B
| $1.93M | 0.1% |
52,120
+17,120
| +49% | +$634K |
|
64
Inhibrx
INBX
$403M
| $1.92M | 0.1% |
+135,546
| New | +$1.92M |
|
65
Keros Therapeutics
KROS
$638M
| $1.52M | 0.08% |
+33,355
| New | +$1.52M |
|
66
uniQure
QURE
$954M
| $1.23M | 0.06% |
274,540
| – | – |
|
67
Iovance Biotherapeutics
IOVA
$800M
| $1.23M | 0.06% |
152,795
-157,959
| -51% | -$1.27M |
|
|
WAY
68
Waystar Holding Corp
WAY
$6.53B
| $753K | 0.04% |
+35,000
| New | +$753K |
|
69
Tenaya Therapeutics
TNYA
$192M
| $689K | 0.03% |
222,222
| – | – |
|
70
Sana Biotechnology
SANA
$759M
| $605K | 0.03% |
110,834
-564,166
| -84% | -$3.08M |
|
|
BOLD
71
Boundless Bio
BOLD
$25.7M
| $544K | 0.03% |
140,513
| – | – |
|
72
iShares China Large-Cap ETF
FXI
$6.65B
| – | – |
-141,122
| Closed | -$3.4M |
|
73
Inspire Medical Systems
INSP
$2.53B
| – | – |
-33,557
| Closed | -$7.21M |
|
74
Align Technology
ALGN
$9.59B
| – | – |
-22,751
| Closed | -$7.46M |
|
75
ARK Innovation ETF
ARKK
$7.43B
| – | – |
-242,260
| Closed | -$12.1M |
|